Abstract: A method for treating mucous membrane inflammation in a patient is provided. The method includes administering an effective amount of a composition containing sodium salts to the patient. Preferably, the composition contains a sodium concentration of less than or equal to 125 mM, and contains sodium hypochlorite and a sodium salt of N-chlorotaurine.

Abstract: A composition for treating inflammation in a patient by administering within an exudate of the patient, which composition includes a concentration of less than or equal to 125 mM of one or more active ingredients salt for treating one or more symptoms of such inflammation, preferably less than or equal to 100 mM, and particularly preferably less than or equal to 75 mM.

Abstract: A method of stimulating tissue healing in humans or animals includes administering to a human or animal suffering from lesions and infections linked to chronic and/or acute periodontitis a pharmaceutically effective amount of a pharmaceutical composition including (i) at least one sodium halopohalite, and (ii) at least one N-halogenated taurine, wherein halogens from the (i) at least one sodium halopohalite and from the (ii) at least one N-haloamine taurine, which may be the same or different, are selected from the group consisting of fluorine, iodine, bromine and chlorine.

Abstract: A method of stimulating tissue healing in humans or animals includes administering to a human or animal suffering from lesions and infections linked to chronic and/or acute periodontitis a pharmaceutically effective amount of a pharmaceutical composition including (i) at least one sodium halopohalite, and (ii) at least one N-halogenated taurine, wherein halogens from the (i) at least one sodium halopohalite and from the (ii) at least one N-haloamine taurine, which may be the same or different, are selected from the group consisting of fluorine, iodine, bromine and chlorine.

Abstract: A method of stimulating tissue healing in humans or animals includes administering to a human or animal a pharmaceutically effective amount of a pharmaceutical composition which includes (i) at least one halogenated compound, and (ii) at least one N-halogenated derivative of at least one compound selected from zwitterionic compounds and/or amino acids or their derivatives.

Abstract: A method of stimulating tissue healing in humans or animals includes administering to a human or animal a pharmaceutically effective amount of a pharmaceutical composition which includes (i) at least one halogenated compound, and (ii) at least one N-halogenated derivative of at least one compound selected from zwitterionic compounds and/or amino acids or their derivatives.

Abstract: The invention concerns pharmaceutical composition including (i) at least a halogenated compound and (ii) at least N-halogenated derivative of at least a compound selected from zwitterionic compounds and/or amino acids. The halogenated compound is advantageously an alkaline metal hypochlorite, and preferably sodium hypochlorite, and N-halogenated derivative is preferably an N-halogenated taurine derivative and particularly a taurine N-haloamine derivative and even more preferably taurine N-chloramine. The invention also concerns the preparation of the compositions and their uses as very large spectrum antiseptic, anti-inflammatory agent and as immunity modulator, without stimulating myeloperoxidase activity.